Newgenivf Group Ltd. (NIVF) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Newgenivf Group Ltd. (NIVF:NASDAQ), powered by AI.

Current Price
$1.02
P/E Ratio
0.0
Market Cap
4,294
Sector
Healthcare
What is the Newgenivf Group Ltd. stock price forecast?

Newgenivf Group Ltd. is currently trading at $1.02. View real-time AI analysis on Alpha Lenz.

What is Newgenivf Group Ltd. insider trading activity?

View the latest insider trading data for Newgenivf Group Ltd. on Alpha Lenz.

What is Newgenivf Group Ltd.'s P/E ratio?

Newgenivf Group Ltd.'s P/E ratio is 0.0.

Newgenivf Group Ltd.

NASDAQ · NIVF
$1.02-0.10(-8.93%)Market closedNASDAQ regular session 09:30–16:00 ET
Ask about Newgenivf Group Ltd.'s future dividend policy...
Alpha Chat Insight

Newgenivf Group Ltd. trades at a P/E of 0.0 (undervalued) with strong ROE of 77.2%.

Ask for details

Company Overview

Newgenivf Group Ltd. is a leading company in the healthcare sector, specializing in advanced fertility treatments and reproductive health services. As a provider of in vitro fertilization (IVF) solutions, Newgenivf plays a crucial role in offering hope and effective treatment options for individuals and couples facing fertility challenges. The company's primary purpose is to enhance reproductive possibilities through cutting-edge technologies and experienced medical professionals. Newgenivf Group Ltd. operates a network of fertility clinics equipped with state-of-the-art laboratories and a team dedicated to research and clinical excellence. The company's services extend beyond IVF to include a wide range of reproductive health care options such as genetic testing, egg and sperm donation programs, and fertility preservation techniques. Its impact is significant in the healthcare industry, touching the lives of patients globally and contributing to the growing assisted reproductive technology market. In a financial context, Newgenivf Group Ltd. is considered a key player in its field, reflecting growth trends in health services and biotechnology. As a publicly traded entity, it offers investors exposure to the burgeoning demand for fertility treatments driven by societal trends and advancements in medical diagnostics and care.

CEOMr. Wing Fung Siu
SectorHealthcare
IndustryMedical Care Facilities
Employees76

Company Statistics

FY 2025

Profile

$4.29KMarket Cap
$4.73MRevenue
0.00Shares Out
76Employees

Margins

20.22%Gross
-223.54%EBITDA
-226.95%Operating
205.84%Pre-Tax
205.84%Net

Valuation

0.00P/E
0.00P/B
0.00EV/Sales
-0.33EV/EBITDA
-0.00P/FCF

Growth (CAGR)

-7.36%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
315.27%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

53.60%ROA
77.23%ROE
57.00%ROIC

Financial Health

$758.62KCash & Cash Equivalents
$5.98MNet Debt
25.92%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Newgenivf Group Ltd. (ticker: NIVF) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 76 employees. Market cap is $4,294.

The current price is $1.02 with a P/E ratio of 0x and P/B of 0x.

ROE is 77.23% and operating margin is -226.95%. Annual revenue is $5M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Newgenivf Group Ltd. (NIVF) Stock Forecast 2026 $1.02 — Price, Financials & Analyst Targets | Alpha Lenz